Specification of dopaminergic subsets involves interplay of En1 and Pitx3

Development (Cambridge)

Volumn 140, Issue 16, 2013, Pages 3373-3384

  Veenvliet, Jesse V ^a   dos Santos, Maria T M Alves ^a,b   Kouwenhoven, Willemieke M ^a   Von Oerthel, Lars ^a   Lim, Jamie L ^b   van der Linden, Annemarie J A ^a,b   Koerkamp, Marian J A Groot ^c   Holstege, Frank C P ^c   Smidt, Marten P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Dopamine; Midbrain; Mouse; Neurodegeneration; Substantia nigra; Transcription

Indexed keywords

EN1 PROTEIN; HISTONE DEACETYLASE; HOMEODOMAIN PROTEIN; NUCLEAR RECEPTOR RELATED FACTOR 1; TRANSCRIPTION FACTOR PITX3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SUBSTANTIA NIGRA PARS COMPACTA;

DOPAMINE; MIDBRAIN; MOUSE; NEURODEGENERATION; SUBSTANTIA NIGRA; TRANSCRIPTION;

ANIMALS; CELL DIFFERENTIATION; DOPAMINERGIC NEURONS; EMBRYO, MAMMALIAN; EMBRYONIC INDUCTION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE DEACETYLASE INHIBITORS; HOMEODOMAIN PROTEINS; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PHENOTYPE; PROTEIN INTERACTION MAPPING; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84880963269     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.094565     Document Type: Article

References (58)

1. Albéri, L., Sgadò, P. and Simon, H. H. (2004). Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131, 3229-3236.
2. Alvarez-Fischer, D., Fuchs, J., Castagner, F., Stettler, O., Massiani-Beaudoin, O., Moya, K. L., Bouillot, C., Oertel, W. H., Lombès, A., Faigle, W. et al. (2011). Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. Nat. Neurosci. 14, 1260-1266.
3. Arenas, E. (2010). Towards stem cell replacement therapies for Parkinson's disease. Biochem. Biophys. Res. Commun. 396, 152-156.
4. Barzilai, A. and Melamed, E. (2003). Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol. Med. 9, 126-132.
5. Bilovocky, N. A., Romito-DiGiacomo, R. R., Murcia, C. L., Maricich, S. M. and Herrup, K. (2003). Factors in the genetic background suppress the engrailed-1 cerebellar phenotype. J. Neurosci. 23, 5105-5112.
6. Boyce, S., Rupniak, N. M., Tye, S., Steventon, M. J. and Iversen, S. D. (1990). Modulatory role for CCK-B antagonists in Parkinson's disease. Clin. Neuropharmacol. 13, 339-347.
7. Bye, C. R., Thompson, L. H. and Parish, C. L. (2012). Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice. Exp. Neurol. 236, 58-68.
8. Caiazzo, M., Dell'Anno, M. T., Dvoretskova, E., Lazarevic, D., Taverna, S., Leo, D., Sotnikova, T. D., Menegon, A., Roncaglia, P., Colciago, G. et al. (2011). Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476, 224-227.
9. Dasen, J. S., Martinez Barbera, J. P., Herman, T. S., Connell, S. O., Olson, L., Ju, B., Tollkuhn, J., Baek, S. H., Rose, D. W. and Rosenfeld, M. G. (2001). Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev. 15, 3193-3207.
10. Di Salvio, M., Di Giovannantonio, L. G., Acampora, D., Prosperi, R., Omodei, D., Prakash, N., Wurst, W. and Simeone, A. (2010). Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP. Nat. Neurosci. 13, 1481-1488.
11. Erickson, T., Scholpp, S., Brand, M., Moens, C. B. and Waskiewicz, A. J. (2007). Pbx proteins cooperate with Engrailed to pattern the midbrain-hindbrain and diencephalic-mesencephalic boundaries. Dev. Biol. 301, 504-517.
12. Fitzmaurice, A. G., Rhodes, S. L., Lulla, A., Murphy, N. P., Lam, H. A., O'Donnell, K. C., Barnhill, L., Casida, J. E., Cockburn, M., Sagasti, A. et al. (2013). Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proc. Natl. Acad. Sci. USA 110, 636-641.
13. Gaillard, A. and Jaber, M. (2011). Rewiring the brain with cell transplantation in Parkinson's disease. Trends Neurosci. 34, 124-133.
14. Ganat, Y. M., Calder, E. L., Kriks, S., Nelander, J., Tu, E. Y., Jia, F., Battista, D., Harrison, N., Parmar, M., Tomishima, M. J. et al. (2012). Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J. Clin. Invest. 122, 2928-2939.
15. Grima, B., Lamouroux, A., Blanot, F., Biguet, N. F. and Mallet, J. (1985). Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl. Acad. Sci. USA 82, 617-621.
16. Grünblatt, E., Zehetmayer, S., Jacob, C. P., Müller, T., Jost, W. H. and Riederer, P. (2010). Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease. J. Neural Transm. 117, 1387-1393.
17. Haubenberger, D., Reinthaler, E., Mueller, J. C., Pirker, W., Katzenschlager, R., Froehlich, R., Bruecke, T., Daniel, G., Auff, E. and Zimprich, A. (2011). Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease. Neurobiol. Aging 32, 302-307.
18. Hwang, D.-Y., Ardayfio, P., Kang, U. J., Semina, E. V. and Kim, K.-S. (2003). Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res. Mol. Brain Res. 114, 123-131
19. Jacobs, F. M. J., Smits, S. M., Noorlander, C. W., von Oerthel, L., van der Linden, A. J. A., Burbach, J. P. H. and Smidt, M. P. (2007). Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development 134, 2673-2684.
20. Jacobs, F. M. J., van Erp, S., van der Linden, A. J. A., von Oerthel, L., Burbach, J. P. H. and Smidt, M. P. (2009a). Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression. Development 136, 531-540.
21. Jacobs, F. M. J., van der Linden, A. J. A., Wang, Y., von Oerthel, L., Sul, H. S., Burbach, J. P. H. and Smidt, M. P. (2009b). Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons. Development 136, 2363-2373.
22. Jacobs, F. M. J., Veenvliet, J. V., Almirza, W. H., Hoekstra, E. J., von Oerthel, L., van der Linden, A. J. A., Neijts, R., Koerkamp, M. G., van Leenen, D., Holstege, F. C. P. et al. (2011). Retinoic acid-dependent and-independent gene-regulatory pathways of Pitx3 in meso-diencephalic dopaminergic neurons. Development 138, 5213-5222.
23. Jayaraman, A., Nishimori, T., Dobner, P. and Uhl, G. R. (1990). Cholecystokinin and neurotensin mRNAs are differentially expressed in subnuclei of the ventral tegmental area. J. Comp. Neurol. 296, 291-302.
24. Joyner, A. L., Liu, A. and Millet, S. (2000). Otx2, Gbx2 and Fgf8 interact to position and maintain a mid-hindbrain organizer. Curr. Opin. Cell Biol. 12, 736-741.
25. Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A. et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551.
26. Lane, R. F., Blaha, C. D. and Phillips, A. G. (1987). Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 11, 291-299.
27. Martinez, S., Crossley, P. H., Cobos, I., Rubenstein, J. L. and Martin, G. R. (1999). FGF8 induces formation of an ectopic isthmic organizer and isthmocerebellar development via a repressive effect on Otx2 expression. Development 126, 1189-1200.
28. Maxwell, S. L., Ho, H.-Y., Kuehner, E., Zhao, S. and Li, M. (2005). Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Dev. Biol. 282, 467-479.
29. Nunes, I., Tovmasan, L. T., Silva, R. M., Burke, R. E. and Goff, S. P. (2003). Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. USA 100, 4245-4250.
30. Peltenburg, L. T. and Murre, C. (1996). Engrailed and Hox homeodomain proteins contain a related Pbx interaction motif that recognizes a common structure present in Pbx. EMBO J. 15, 3385-3393.
31. Qin, P., Haberbusch, J. M., Soprano, K. J. and Soprano, D. R. (2004). Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally. J. Cell. Biochem. 92, 147-163
32. Roepman, P., Wessels, L. F. A., Kettelarij, N., Kemmeren, P., Miles, A. J., Lijnzaad, P., Tilanus, M. G. J., Koole, R., Hordijk, G.-J., van der Vliet, P. C. et al. (2005). An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat. Genet. 37, 182-186.
33. Rotzinger, S. and Vaccarino, F. J. (2003). Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. J. Psychiatry Neurosci. 28, 171-181.
34. Saucedo-Cardenas, O., Quintana-Hau, J. D., Le, W. D., Smidt, M. P., Cox, J. J., De Mayo, F., Burbach, J. P. and Conneely, O. M. (1998). Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95, 4013-4018.
35. Serrano, N. and Maschat, F. (1998). Molecular mechanism of polyhomeotic activation by Engrailed. EMBO J. 17, 3704-3713.
36. Sgadò, P., Albéri, L., Gherbassi, D., Galasso, S. L., Ramakers, G. M. J., Alavian, K. N., Smidt, M. P., Dyck, R. H. and Simon, H. H. (2006). Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc. Natl. Acad. Sci. USA 103, 15242-15247.
37. Sgadò, P., Ferretti, E., Grbec, D., Bozzi, Y. and Simon, H. H. (2012). The atypical homeoprotein Pbx1a participates in the axonal pathfinding of mesencephalic dopaminergic neurons. Neural Dev. 7, 24.
38. Shamim, H., Mahmood, R., Logan, C., Doherty, P., Lumsden, A. and Mason, I. (1999). Sequential roles for Fgf4, En1 and Fgf8 in specification and regionalisation of the midbrain. Development 126, 945-959
39. Simon, H. H., Saueressig, H., Wurst, W., Goulding, M. D. and O'Leary, D. D. (2001). Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21, 3126-3134.
40. Simon, H. H., Bhatt, L., Gherbassi, D., Sgadó, P. and Alberí, L. (2003). Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann. New York Acad. Sci. 991, 36-47.
41. Smidt, M. P. and Burbach, J. P. H. (2007). How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 8, 21-32.
42. Smidt, M. P., van Schaick, H. S., Lanctôt, C., Tremblay, J. J., Cox, J. J., van der Kleij, A. A., Wolterink, G., Drouin, J. and Burbach, J. P. (1997). A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. USA 94, 13305-13310.
43. Smidt, M. P., Smits, S. M., Bouwmeester, H., Hamers, F. P. T., van der Linden, A. J. A., Hellemons, A. J. C. G. M., Graw, J. and Burbach, J. P. H. (2004). Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131, 1145-1155.
44. Smits, S. M., Ponnio, T., Conneely, O. M., Burbach, J. P. H. and Smidt, M. P. (2003). Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 18, 1731-1738.
45. Smits, S. M., Terwisscha van Scheltinga, A. F., van der Linden, A. J. A., Burbach, J. P. H. and Smidt, M. P. (2004). Species differences in brain pre-pro-neurotensin/neuromedin N mRNA distribution: the expression pattern in mice resembles more closely that of primates than rats. Brain Res. Mol. Brain Res. 125, 22-28.
46. Smits, S. M., Burbach, J. P. H. and Smidt, M. P. (2006). Developmental origin and fate of meso-diencephalic dopamine neurons. Prog. Neurobiol. 78, 1-16
47. Sonnier, L., Le Pen, G., Hartmann, A., Bizot, J.-C., Trovero, F., Krebs, M.-O. and Prochiantz, A. (2007). Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J. Neurosci. 27, 1063-1071.
48. Toulouse, A. and Sullivan, A. M. (2008). Progress in Parkinson's disease-where do we stand? Prog. Neurobiol. 85, 376-392.
49. Van den Heuvel, D. M. A. and Pasterkamp, R. J. (2008). Getting connected in the dopamine system. Prog. Neurobiol. 85, 75-93.
50. van den Munckhof, P., Luk, K. C., Ste-Marie, L., Montgomery, J., Blanchet, P. J., Sadikot, A. F. and Drouin, J. (2003). Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130, 2535-2542.
51. Van Heesbeen, H. J., Mesman, S., Veenvliet, J. V. and Smidt, M. P. (2013). Epigenetic mechanisms in the development and maintenance of dopaminergic neurons. Development 140, 1159-1169.
52. Vitobello, A., Ferretti, E., Lampe, X., Vilain, N., Ducret, S., Ori, M., Spetz, J.-F., Selleri, L. and Rijli, F. M. (2011). Hox and Pbx factors control retinoic acid synthesis during hindbrain segmentation. Dev. Cell 20, 469-482
53. Wallén, A., Zetterström, R. H., Solomin, L., Arvidsson, M., Olson, L. and Perlmann, T. (1999). Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 253, 737-746.
54. Wey, M. C.-Y., Fernandez, E., Martinez, P. A., Sullivan, P., Goldstein, D. S. and Strong, R. (2012). Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease. PLoS ONE 7, e31522.
55. Wu, H., Kerr, M., Cui, X. and Churchill, G. (2003). MAANOVA: a software package for the analysis of spotted cDNA microarray experiments. In The Analysis of Gene Expression Data: Methods and Software, pp. 313-341. Springer.
56. Wurst, W., Auerbach, A. B. and Joyner, A. L. (1994). Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum. Development 120, 2065-2075
57. Zetterström, R. H., Solomin, L., Jansson, L., Hoffer, B. J., Olson, L. and Perlmann, T. (1997). Dopamine neuron agenesis in Nurr1-deficient mice. Science 276, 248-250.
58. Zhao, S., Maxwell, S., Jimenez-Beristain, A., Vives, J., Kuehner, E., Zhao, J., O'Brien, C., de Felipe, C., Semina, E. and Li, M. (2004). Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur. J. Neurosci. 19, 1133-1140.